Physician profile
Jon A Chapman
NPI 1154349306
$3,248.60
in general payments reported to CMS, 2019-2025
12 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2021: $93.34 · 2022: $122 · 2023: $625 · 2024: $1,848 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,878.30 |
| Travel and Lodging | $928.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,804.54 | 2019-2025 | Acuvue, Axert |
| Alcon Vision LLC | $402.37 | 2019-2024 | Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $313.40 | 2023-2025 | Infuse, Xiidra |
| Coopervision INC. | $281.15 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $145.18 | 2024 | Xdemvy |
| Abbvie INC. | $102.15 | 2023 | Xen Glaucoma Treatment System |
| Allergan, INC. | $69.99 | 2021-2022 | |
| Carl Zeiss Meditec, INC. | $45.69 | 2019 | |
| Biotissue Holdings INC. | $29.04 | 2025 | |
| Sun Pharmaceutical Industries INC. | $22.33 | 2024 | |
| Novartis Pharmaceuticals Corporation | $19.13 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.